Close
ACHEMA MIDDLE EAST 2026
5th LNP Formulation & Process Development Summit

Drug Development

      Recro Expands Development and Manufacturing Relationship With Ensysce Biosciences

      Drug Development
      Recro Pharma, Inc. , a contract development and manufacturing organization dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose...

      Charles River and Valence Discovery Announce Strategic Partnership to Provide Clients with AI-Enabled Drug Design Capabilities

      Drug Development
      Charles River Laboratories International, Inc. and Valence Discovery announced the formation of a strategic partnership to provide clients access to Valence’s artificial intelligence platform...

      AB Science and University of Chicago to conduct Covid-19 treatment research

      Drug Development
      AB Science SA, together with the University of Chicago, announces the signing of an exclusive licensing agreement for conducting research on the prevention and...

      Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients

      Clinical Trials
      Eli Lilly and Company and Incyte announced results of COV-BARRIER, a Phase 3 study evaluating baricitinib 4 mg once daily plus standard of care...

      FDA accepts Airway Therapeutics IND application for Covid-19

      FDA Approvals
      The US FDA has accepted Airway Therapeutics’ Investigational New Drug (IND) application to develop AT-100 (rhSP-D) for treating Covid-19. A new recombinant human protein rhSP-D,...

      Fujifilm Diosynth Biotechnologies Biologics Production Facility Expansion

      Drug Development
      Fujifilm Diosynth Biotechnologies (FDB), a subsidiary of Japanese multinational conglomerate Fujifilm, is expanding its large-scale biologics production facility in Hillerod, Denmark. In June 2020, Fujifilm...

      Oxford University expands Com-COV2 dose-mixing study with Novavaxs Covid-19 vaccine

      Drug Development
      The University of Oxford has expanded the Comparing Covid-19 Vaccine Schedule Combinations – Stage 2 (Com-COV2) study to include the Novavax and Moderna vaccines...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.